Barriers to Timely Follow-up for Heart Failure Hospitalization
Researchers examine patient barriers when receiving follow-up for heart failure hospitalization.
Researchers examine patient barriers when receiving follow-up for heart failure hospitalization.
Researchers sought to determine the rate of stroke in patients with heart failure with preserved ejection fraction without atrial fibrillation.
Recent FDA approvals include treatments for postpartum depression, RSV in infants, pediatric constipation, metastatic colorectal cancer, and iron deficiency.
Self-reported health status better for patients increasing step counts over 12 weeks.
Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment.
Researchers studied the effect of nutritional status on the association between obesity and mortality among patients with acute heart failure.
Inpefa is expected to be available by the end of June 2023.
Hemodynamic monitoring improved Kansas City Cardiomyopathy Questionnaire with CardioMEMS-HF system vs standard care
Dapagliflozin is sodium-glucose cotransporter 2 inhibitor.
Researchers studied the effect of gout on cardiovascular events, including CVD and heart failure, in a Black urban population.